Video

Dr. Jang on current state of immunotherapy in advanced GU cancers

Author(s):

Urology Times staff
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      Albert Jang, MD, a 3rd-year internal resident physician at Tulane University, discusses progress and unmet needs with immunotherapy for the treatment of patients with genitourinary cancers.

      Newsletter

      Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

      Subscribe Now!
      Related Videos
      Martin Sanda, MD, considers potential future advancements in urology
      Martin Sanda, MD, considers potential future advancements in urology
      Daniel Carson, MD, MS, answers a question during a Zoom video interview
      Dr. Daniel Carson on telehealth vs in-person urology visits
      Laura Bukavina, MD, on the need to integrate mental health support in GU cancer care
      Laura Bukavina, MD, on the need to integrate mental health support in GU cancer care
      Study: GU cancer survivors report difficulty affording mental health, dental care
      Study: GU cancer survivors report difficulty affording mental health, dental care
      Dr. Cary details the history of IU’s testicular cancer program
      Dr. Cary details the history of IU’s testicular cancer program
      Dr. Neal E. Rowe in an interview with Urology Times
      Dr. Rowe highlights AUA course on the management of adrenal tumors
      Dr. Rowe on potential future work with incidental adrenal tumors
      Dr. Rowe on potential future work with incidental adrenal tumors
      Developments in the penile cancer treatment paradigm
      Developments in the penile cancer treatment paradigm
      Why clinicians should join the Global Society of Rare Genitourinary Tumors
      Why clinicians should join the Global Society of Rare Genitourinary Tumors
      Dr. Spiess and Dr. Necchi on new society for rare GU cancers
      Dr. Spiess and Dr. Necchi on new society for rare GU cancers
      Related Content
      Ultrasound imaging system now available to guide nonsurgical urology procedures
      June 16th 2025

      Ultrasound imaging system now available to guide nonsurgical urology procedures

      Hannah Clarke
      The bkActiv S series is designed to guide nonsurgical urologic, colorectal, and pelvic floor procedures.
      Destigmatizing Urology: Dr. Pettaway discusses penile cancer
      March 29th 2022

      Destigmatizing Urology: Dr. Pettaway discusses penile cancer

      Urology Times staff
      “When you compound the patient delay and…the physician delay, then you really get a delay in diagnosis,” says Curtis A. Pettaway, MD.
      Enrollment progresses in study for cisplatin-induced hearing loss in testicular cancer
      May 14th 2025

      Enrollment progresses in study for cisplatin-induced hearing loss in testicular cancer

      Hannah Clarke
      ACOU085 will be administered in 1 ear, with a matching placebo injection in the respective contralateral middle ear.
      Dr. Richard Matulewicz discusses smoking cessation counseling and treatment among urologists
      March 31st 2021

      Dr. Richard Matulewicz discusses smoking cessation counseling and treatment among urologists

      Urology Times staff
      “Because so many disease processes that we deal with are related to tobacco use and smoking specifically… I think this is absolutely our domain,” says Richard S. Matulewicz, MD, of tobacco cessation counseling and treatment.
      Urologist speaking with a male patient following a diagnosis of cancer. | Credit: Adobe Stock
      February 4th 2025

      Urologic Cancer Facts and Updates for World Cancer Day 2025

      Patrick Campbell
      A list of facts and trends to know about the current landscape of urologic cancer management and research in the US.
      Blur image of hospital corridor | Image Credit: © zephyr_p - stock.adobe.com
      January 30th 2025

      The evolving role of microRNAs in testicular cancer management

      Kshitij Pandit, MBBS Krinio Giannikou, PhD, MSc Jane Smitham Sarah Murray, PhD, FACMG Aditya Bagrodia, MD
      "This brief review captures the evolving role of miRNAs, focusing on their clinical relevance and implications as well as future directions for more effective targeted therapeutic interventions," write the authors.
      © 2025 MJH Life Sciences

      All rights reserved.